A new method for the comparison of the treatment efficacy for specific diseases or conditions between Chinese medicine and Western medicine, which serve the same medical aim but are based on substantially different th...A new method for the comparison of the treatment efficacy for specific diseases or conditions between Chinese medicine and Western medicine, which serve the same medical aim but are based on substantially different theoretical systems, was identified. Abiding by the principle of parallel subgroup design of a randomized controlled trial (PSD-RCT), participants were recruited following identical inclusion and exclusion criteria and were randomly allocated into two groups to receive treatment using the respective approaches of Chinese medicine and Western medicine. The Chinese medicine group was divided into subgroups according to the theory of Chinese medicine and the Western medicine group was also divided into subgroups according to the theory of Western medicine. The treatment for each subgroup was well defined in the protocol, including major formulae and principles for individualized modifications. The primary outcome measure was ascertained to be directly related to the patients' status but independent from both theories of Chinese medicine and Western medicine, while the secondary outcomes were represented by the patient-reported outcomes and some laboratory tests commonly accepted by Chinese medicine and Western medicine. Then, taking functional dyspepsia as an example, the authors explain the framework of the PSD-RCT for efficacy comparisons between Chinese medicine and Western medicine, and recommend that the PSD-RCT can be used to compare treatment efficacy for a specific disease or condition between Chinese medicine and Western medicine, and the comparison among subgroups can provide valuable clues for further studies.展开更多
文摘A new method for the comparison of the treatment efficacy for specific diseases or conditions between Chinese medicine and Western medicine, which serve the same medical aim but are based on substantially different theoretical systems, was identified. Abiding by the principle of parallel subgroup design of a randomized controlled trial (PSD-RCT), participants were recruited following identical inclusion and exclusion criteria and were randomly allocated into two groups to receive treatment using the respective approaches of Chinese medicine and Western medicine. The Chinese medicine group was divided into subgroups according to the theory of Chinese medicine and the Western medicine group was also divided into subgroups according to the theory of Western medicine. The treatment for each subgroup was well defined in the protocol, including major formulae and principles for individualized modifications. The primary outcome measure was ascertained to be directly related to the patients' status but independent from both theories of Chinese medicine and Western medicine, while the secondary outcomes were represented by the patient-reported outcomes and some laboratory tests commonly accepted by Chinese medicine and Western medicine. Then, taking functional dyspepsia as an example, the authors explain the framework of the PSD-RCT for efficacy comparisons between Chinese medicine and Western medicine, and recommend that the PSD-RCT can be used to compare treatment efficacy for a specific disease or condition between Chinese medicine and Western medicine, and the comparison among subgroups can provide valuable clues for further studies.
文摘目的:观察温胆汤加减联合胆经五输穴放血治疗胆郁痰扰型失眠疗效。方法:使用随机平行对照方法,将46例门诊患者按随机分为两组。对照组23例口服地西泮片,起始剂量每次2.5 mg,1次/d,以后可根据病情增至每次10 mg,1次/d。治疗组23例温胆汤(半夏10 g,枳实15 g,竹茹15 g,陈皮15 g,茯苓25 g,大枣10 g,生姜5 g,炙甘草10 g),加水1000 m L,煎后200 m L,2次/d,100 m L/次,温服;胆经五输穴放血,3 d 1次。对照组与治疗组均连续治疗15 d为1个疗程。观察临床症状、睡眠时间、不良反应。结果:治疗组显效19例,有效3例,无效1例,总有效率95.65%;对照组显效14例,有效4例,无效5例,总有效率78.26%。治疗组疗效优于对照组(P<0.05)。结论:温胆汤联合胆经五输穴放血治疗胆郁痰扰型失眠效果显著,值得在临床上广泛推广。
文摘目的:研究沙棘柴术胶囊治疗单纯性肥胖症的疗效及其对性激素睾酮(testosterone,T)、黄体生成素/促卵泡激素(luteinizing hormone/follicle-stimulating hormone,LH/FSH)的影响。方法:采用随机、双盲、平行对照的试验设计方法,选取120例女性成人体质指数(body mass index,BMI)≥30的单纯性肥胖自愿受试患者,按照1:1的比例进行随机分组,试验组与对照组各60例,试验组服用沙棘柴术胶囊,对照组服用安慰剂,疗程60天。试验过程中试验组脱落2例,对照组脱落3例。试验结束揭盲后,分析沙棘柴术胶囊治疗单纯性肥胖症的疗效以及对性激素T、LH/FSH比值的影响。结果:试验组患者试验前后体质量、BMI、腰围、臀围、皮下脂肪厚度(B、C、D点)、体脂含量等均低于试验前,差异具有统计学意义(P<0.05),且T、LH/FSH水平低于对照组,差异具有统计学意义(P<0.05)。结论:沙棘柴术胶囊不仅可以有效治疗肥胖症,还可通过调节性激素T、LH/FSH等水平预防发生多囊卵巢综合征。